Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

HIF signaling pathway in pheochromocytoma and other neuroendocrine tumors

I. Jochmanová, T. Zelinka, J. Widimský, K. Pacak

. 2014 ; 63 (Suppl. 2) : S251-S262.

Language English Country Czech Republic

Document type Journal Article, Research Support, Non-U.S. Gov't, Review

Hypoxia-inducible factors (HIFs) are transcription factors controlling energy, iron metabolism, erythropoiesis, and development. Dysregulation of these proteins contributes to tumorigenesis and cancer progression. Recent findings revealed the important role of HIFs in the pathogenesis of neuroendocrine tumors, especially pheochromocytoma (PHEO) and paraganglioma (PGL). PHEOs and PGLs are catecholamine-producing tumors arising from sympathetic- or parasympathetic-derived chromaffin tissue. To date, eighteen PHEO/PGL susceptibility genes have been identified. Based on the main signaling pathways, PHEOs/PGLs have been divided into two clusters, pseudohypoxic cluster 1 and cluster 2, rich in kinase receptor signaling and protein translation pathways. Recent data suggest that both clusters are interconnected via the HIF signaling and its role in tumorigenesis is supported by newly described somatic and germline mutations in HIF2A gene in patients with PHEOs/PGLs associated with polycythemia, and in some of them also with somatostatinoma. Moreover, HIFalpha signaling has also been shown to be upregulated in neuroendocrine tumors other than PHEO/PGL. Some of these tumors are components of hereditary tumor syndromes which can be associated with PHEO/PGL, but also in ileal carcinoids or melanoma. HIF signaling appears to be one of the crucial players in tumorigenesis, which could suggest new therapeutic approaches for treatment of neuroendocrine tumors.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15008964
003      
CZ-PrNML
005      
20170106084342.0
007      
ta
008      
150305s2014 xr f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.932789 $2 doi
035    __
$a (PubMed)24908231
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Jochmanová, Ivana. $u Department of Internal Medicine, Faculty of Medicine, P. J. Šafárik University, Košice, Slovakia; Section on Medical Neuroendocrinology, Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver NICHD, NIH, Bethesda, MD, USA. karel@mail.nih.gov. $7 xx0267304
245    10
$a HIF signaling pathway in pheochromocytoma and other neuroendocrine tumors / $c I. Jochmanová, T. Zelinka, J. Widimský, K. Pacak
520    9_
$a Hypoxia-inducible factors (HIFs) are transcription factors controlling energy, iron metabolism, erythropoiesis, and development. Dysregulation of these proteins contributes to tumorigenesis and cancer progression. Recent findings revealed the important role of HIFs in the pathogenesis of neuroendocrine tumors, especially pheochromocytoma (PHEO) and paraganglioma (PGL). PHEOs and PGLs are catecholamine-producing tumors arising from sympathetic- or parasympathetic-derived chromaffin tissue. To date, eighteen PHEO/PGL susceptibility genes have been identified. Based on the main signaling pathways, PHEOs/PGLs have been divided into two clusters, pseudohypoxic cluster 1 and cluster 2, rich in kinase receptor signaling and protein translation pathways. Recent data suggest that both clusters are interconnected via the HIF signaling and its role in tumorigenesis is supported by newly described somatic and germline mutations in HIF2A gene in patients with PHEOs/PGLs associated with polycythemia, and in some of them also with somatostatinoma. Moreover, HIFalpha signaling has also been shown to be upregulated in neuroendocrine tumors other than PHEO/PGL. Some of these tumors are components of hereditary tumor syndromes which can be associated with PHEO/PGL, but also in ileal carcinoids or melanoma. HIF signaling appears to be one of the crucial players in tumorigenesis, which could suggest new therapeutic approaches for treatment of neuroendocrine tumors.
650    _2
$a nádory nadledvin $x genetika $x metabolismus $x patologie $7 D000310
650    _2
$a zvířata $7 D000818
650    _2
$a transkripční faktory bHLH $x genetika $x metabolismus $7 D051792
650    _2
$a lidé $7 D006801
650    _2
$a faktor 1 indukovatelný hypoxií - podjednotka alfa $x metabolismus $7 D051795
650    _2
$a neuroendokrinní nádory $x genetika $x metabolismus $x patologie $7 D018358
650    _2
$a feochromocytom $x genetika $x metabolismus $x patologie $7 D010673
650    _2
$a prognóza $7 D011379
650    12
$a signální transdukce $7 D015398
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Zelinka, Tomáš $7 xx0074465 $u Third Department of Medicine, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Widimský, Jiří, $d 1956- $7 jn99240001422 $u Third Department of Medicine, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Pacák, Karel, $d 1958- $7 jo20000074102 $u Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, USA
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 63, Suppl. 2 (2014), s. S251-S262
773    0_
$t Professor Schreiber celebrates his 90th birthday $g (2014), s. S251-S262 $w MED00190346
856    41
$u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20150305 $b ABA008
991    __
$a 20170106084434 $b ABA008
999    __
$a ok $b bmc $g 1066878 $s 891767
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 63 $c Suppl. 2 $d S251-S262 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
BMC    ##
$a 2014 $d S251-S262 $m Professor Schreiber celebrates his 90th birthday $x MED00190346
LZP    __
$b NLK118 $a Pubmed-20150305

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...